Pricing Log in Create free account

Alzamend Neuro, Inc. (ALZN) vs MetaVia Inc. (MTVA)

Alzamend Neuro, Inc. and MetaVia Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and MetaVia Inc. are of similar size ($7.5M and $7.2M). Across the 9 metrics below, Alzamend Neuro, Inc. leads on 6 and MetaVia Inc. on 3.

Valuation

Metric ALZN MTVA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 1.10 1.22 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.10 0.04 0.66
EV/Sales n/m n/m 9.02
Earnings yield (160.84%) (285.73%) (32.88%)
Free cash flow yield (111.54%) (190.70%) (23.13%)

Profitability

Metric ALZN MTVA Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.23%) (175.68%) (51.96%)
Return on assets (122.36%) (91.06%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALZN MTVA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 76.77% 81.23% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALZN MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 2.06 4.97
Net debt to EBITDA 0.08 0.75 1.01

Dividend

Metric ALZN MTVA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALZN MTVA Biotechnology median
Market cap 7.48m 7.18m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack